Tadalafil: all 193 studies that test it
Page 2 of 2. Open to participants first (21), then studies with results posted, then the rest; newest registration first within each.
- The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate BiopsyStatus unknownNCT05537272Phase 4
- Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OABStatus unknownNCT05494567Phase 4
- Investigational and Comparative Study in the Management of Diabetic NephropathyCompletedNCT05487755Phase 3
- Comparing The Effect of Tadalafil 5 mg/Day to Sildenafil 25 mg/Day on Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Erectile Dysfunction Patients; and Comparison of Clinical ResponseStatus unknownNCT05466695Early Phase 1
- Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile DysfunctionCompletedNCT05446493Phase 4
- Efficiency of Tadalafil for Management of Female Sexual DysfunctionStatus unknownNCT05266651Phase 2/3
- A Study of Fixed Dose Combination of Macitentan/Tadalafil (10 mg/20 mg) Compared to the Reference Free Combination of Macitentan and Tadalafil in Healthy Adult ParticipantsCompletedNCT05236231Phase 1
- Tadalafil as Adjuvant Therapy for DMDActive, not recruitingNCT05195775Phase 2/3
- Improving Cerebral Blood Flow and Cognition in Patients with Cerebral Small Vessel Disease. the ETLAS-2 TrialActive, not recruitingNCT05173896Phase 2
- Impact of Tadalafil 5 mg on Post-micturition Dribble in Young-age Men With no/Mild Lower Urinary Tract SymptomsStatus unknownNCT05146674Not applicable
- A Trial for Prevention of Recurrent Ischemic Priapism in Men With Sickle Cell Disease: A Pilot StudyCompletedNCT05142254Phase 2
- Endocan Level in Patients With Erectile Dysfunction and Relationship With Tadalafil TreatmentStatus unknownNCT05109377Not applicable
- Effects of Single Dose Tadalafil on Urethral and Anal Closure FunctionCompletedNCT05095077Phase 1
- The Phosphodiesterase Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder PatientsWithdrawnNCT05030623Phase 1/2
- Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV AstrocytomaCompletedNCT04757662Phase 1
- A Study of Macitentan/Tadalafil Combination Administered a Fixed-dose Combination Formulation Compared to the Reference Free Combination of Macitentan and TadalafilCompletedNCT04540744Phase 1
- Low Dose Tadalafil for Treatment of Female OAB Syndrome: Short Term Follow up.CompletedNCT04500860Phase 1
- Study of Pharmacological Treatment in Women With Female Sexual Interest/Arousal Disorder (FSIAD).Status unknownNCT04433559Phase 3
- A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult ParticipantsCompletedNCT04235270Phase 1
- Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLCTerminatedNCT04069936Phase 2
- Effect of Tadalafil Administration on Vasodilatation Mediated by Flow in Patients With Obesity Grade I-IIStatus unknownNCT03905018Phase 3
- Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile DysfunctionCompletedNCT03834610Not applicable
- Tadalafil for Erectile Dysfunction in Patients With CirrhosisCompletedNCT03566914Not applicable
- Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary HypertensionWithdrawnNCT03309592Phase 4
- Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia PatientsCompletedNCT03246880Phase 3
- Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and NeckCompletedNCT03238365Early Phase 1
- Trial of Tadalafil, Tamsulosin and Combination for Access Sheath DeploymentCompletedNCT03229889Phase 4
- A Study to Compare the Macitentan-tadalafil Fixed Dose Combination Tablet Relative to the Concomitant Administration of the Reference Tablets of Macitentan and Tadalafil in Healthy SubjectsCompletedNCT03215966Phase 1
- Hookah Smoking, Carbon Monoxide, and Coronary Endothelial FunctionTerminatedNCT03166787Phase 1
- Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and FunctionCompletedNCT03049540Phase 3
- Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal MalignancyCompletedNCT02998736Phase 1
- Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA)TerminatedNCT02968901Phase 4
- Effect of Tadalafil on Erectile Dysfunction Treatment and QOL Improvement Effect (by SF-12) in Andropause Patients With Erectile DysfunctionStatus unknownNCT02943356Phase 4
- A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male SubjectsCompletedNCT02839122Phase 1
- Effect of Tadalafil on Cerebral Large Arteries in StrokeCompletedNCT02801032Phase 2
- The Study of Skeletal Muscle Blood Flow in Becker Muscular DystrophyTerminatedNCT02653833Early Phase 1
- Endocrine Cardiomyopathy: Response to Cyclic GMP PDE5 Inhibitors in Acromegaly CardiomyopathyCompletedNCT02611336Phase 2
- Endocrine Cardiomyopathy in Cushing Syndrome: Response to Cyclic GMP PDE5 inhibitOrsCompletedNCT02611258Phase 2
- Effects on Insulin Resistance With Tadalafil in Type 2 Diabetes - a Double-blind, Placebo-controlled Crossover StudyCompletedNCT02601989Phase 2
- Daily Tadalafil on Body Fat and Lean MassCompletedNCT02554045Phase 4
- PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCCCompletedNCT02544880Phase 1
- Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) TrialCompletedNCT02450253Phase 2
- Pharmacokinetic of Tadalafil Co-administered With Tipranavir/Ritonavir to Healthy Male VolunteersCompletedNCT02253862Phase 1
- Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract SymptomsCompletedNCT02252367Phase 4
- CKD-397 Drug-drug Interaction Study (A)CompletedNCT02247518Phase 1
- CKD-397 Drug-drug Interaction Study (B)CompletedNCT02247505Phase 1
- Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and TamsulosinCompletedNCT02239484Phase 1
- Sagene 2014 - Parkinson's Disease and Erectile DysfunctionStatus unknownNCT02225548Phase 4
- Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure: Extent of Renal DamageWithdrawnNCT01960153Phase 3
- Safety and Pharmacokinetic Interaction Study of Tadalafil and DutasterideCompletedNCT01942551Phase 1
- Chemoimmunotherapy and Radiation in Pancreatic CancerCompletedNCT01903083Phase 1
- REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrsCompletedNCT01803828Phase 4
- Tadalafil Effects in Left Ventricle Diastolic Dysfunction in Resistant Hypertensive PatientsCompletedNCT01743911Not applicable
- PDE Inhibitors in DMD Study (Acute Dosing Study)CompletedNCT01580501Phase 1
- A Trial of Tadalafil in Interstitial Lung Disease of SclerodermaCompletedNCT01553981Phase 3
- Evaluation of Safety and Effectiveness of 2 Lower Dose Combined PDE5i's Versus Single Maximal Dose PDE5i TreatmentStatus unknownNCT01364701Phase 4
- Tadalafil and Sildenafil for Duchenne Muscular DystrophyCompletedNCT01359670Early Phase 1
- Immunochemoradiotherapy in Patients With Pancreatic CancerCompletedNCT01342224Phase 1
- Daily Tadalafil and Gastric Emptying Time in Diabetic GastroparesisWithdrawnNCT01326117Phase 4
- Effect of Tadalafil on Exercise Capacity in Pediatric Fontan PatientsCompletedNCT01291069Phase 1
- Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 DiabetesTerminatedNCT01238224Phase 1
- Do Phosphodiesterase 5A Inhibitors Improve Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Hypertension?CompletedNCT01197469Phase 2
- A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in SclerodermaCompletedNCT01117298Phase 3
- Tadalafil in Becker Muscular DystrophyCompletedNCT01070511Phase 4
- Effect of Tadalafil (Cialis) on the Cardiovascular System of Spinal Cord Injury (SCI) MalesCompletedNCT01067391Phase 4
- Tadalafil and Acetazolamide Versus Acetazolamide in Acute Mountain Sickness PreventionCompletedNCT01060969Not applicable
- Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual DysfunctionCompletedNCT00707187Phase 2
- Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.Status unknownNCT00705588Phase 4
- A Randomized, Open-Label, Crossover, Multicenter, Single Dose Comparator Study Evaluating Onset Of Penile Rigidity In Men With Erectile Dysfunction Who Are Treated With Sildenafil And TadalafilCompletedNCT00644956Phase 4
- Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract ProblemsCompletedNCT00547625Phase 2
- Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil EffectsCompletedNCT00547599Phase 4
- Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an ErectionCompletedNCT00547573Phase 3
- To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After TakingCompletedNCT00547508Phase 3
- Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an ErectionCompletedNCT00547495Phase 3
- To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for ErectionsCompletedNCT00547417Phase 3
- Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an ErectionCompletedNCT00547352Phase 4
- Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across NationsCompletedNCT00547287Phase 3
- Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an ErectionCompletedNCT00547183Phase 3
- Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining an ErectionCompletedNCT00547092Phase 4
- Tadalafil for Treatment of Priapism in Men With Sickle Cell AnemiaWithdrawnNCT00538564Phase 2
- Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary HypertensionWithdrawnNCT00506701Not applicable
- Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile DysfunctionCompletedNCT00422578Phase 4
- Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord InjuryCompletedNCT00421083Phase 3
- A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mgCompletedNCT00382135Phase 4
- A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile DysfunctionCompletedNCT00381732Phase 3
- Efficacy and Safety of Tadalafil in Hemodialysis PatientsStatus unknownNCT00334477Phase 2
- A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for Six MonthsCompletedNCT00333281Phase 4
- Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?TerminatedNCT00215631Phase 3
- Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile DysfunctionCompletedNCT00174486Phase 2
- Tadalafil in Subjects With Mild to Moderate HypertensionCompletedNCT00157326Phase 2
- PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00125918Phase 3
- A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate CancerCompletedNCT00122499Phase 3
- Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach EmptyingCompletedNCT00050609Phase 2